A longitudinal single-cell atlas of treatment response in pediatric AML.
Autorzy:
Lambo S; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada. Trinh DL; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada. RiesRE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Jin D; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada. Setiadi A; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, Division of Hematopathology, Children's and Women's Health Centre of British Columbia, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. Ng M; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada; Department of Medical Genetics and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada. Leblanc VG; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada. Loken MR; Hematologics, Incorporated, Seattle, WA, USA. Brodersen LE; Hematologics, Incorporated, Seattle, WA, USA. Dai F; Hematologics, Incorporated, Seattle, WA, USA. Pardo LM; Hematologics, Incorporated, Seattle, WA, USA. Ma X; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Vercauteren SM; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, Division of Hematopathology, Children's and Women's Health Centre of British Columbia, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Marra MA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada; Department of Medical Genetics and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada. Electronic address: .
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2023 Dec 11; Vol. 41 (12), pp. 2117-2135.e12. Date of Electronic Publication: 2023 Nov 16.
Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group.
Autorzy:
Hoff FW; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Qiu Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Brown BD; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Gerbing RB; COG Statistics and Data Center, Monrovia, California, USA. Leonti AR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. RiesRE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. Gamis AS; Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, Missouri, USA. Aplenc R; Division of Pediatric Oncology/Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Kolb EA; Nemours Center for Cancer and Blood Disorders, Alfred I. DuPont Hospital for Children, Wilmington, Delaware, USA. Alonzo TA; COG Statistics and Data Center, Monrovia, California, USA.; Keck School of Medicine, University of Southern California, Los Angeles, California, USA. Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. Jenkins GN; Department of Pediatrics, Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Cancer Center, Houston, Texas, USA. Horton TM; Department of Pediatrics, Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Cancer Center, Houston, Texas, USA. Kornblau SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Proteomics. Clinical applications [Proteomics Clin Appl] 2023 Nov; Vol. 17 (6), pp. e2200109. Date of Electronic Publication: 2023 Jun 07.
Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia.
Autorzy:
Bertrums EJM; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology/Hematology, Erasmus Medical Center - Sophia Children's Hospital, Rotterdam, the Netherlands; Oncode Institute, Utrecht. . Smith JL; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA. Harmon L; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI. RiesRE; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA. Wang YJ; Department of Translational Genomics, University of Southern California, Los Angeles, CA, USA; Children's Oncology Group, Monrovia, CA. Alonzo TA; Department of Translational Genomics, University of Southern California, Los Angeles, CA, USA; Children's Oncology Group, Monrovia, CA. Menssen AJ; Hematologics, Inc, Seattle, WA. Chisholm KM; Department of Laboratories, Seattle Children's Hospital, Seattle, WA. Leonti AR; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA. Tarlock K; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA; Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA. Ostronoff F; Intermountain Blood and Marrow Transplant and Acute Leukemia Program, Intermountain Healthcare, Salt Lake City, UT. Pogosova-Agadjanyan EL; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA. Kaspers GJL; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, The Netherlands; Dutch Childhood Oncology Group. Hasle H; Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark. Dworzak M; Children's Cancer Research Institute, Medical University of Vienna, Vienna, Austria; St. Anna Kinderspital, Department of Pediatrics, Medical University of Vienna, Vienna. Walter C; Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen. Muhlegger N; Children's Cancer Research Institute, Medical University of Vienna, Vienna. Morerio C; Laboratory of Human Genetics, IRCCS Istituto Giannina Gaslini, Genoa. Pardo L; Hematologics, Inc, Seattle, WA. Hirsch B; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN. Raimondi S; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN. Cooper TM; Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA. Aplenc R; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA. Gamis AS; Division of Hematology/Oncology, Children's Mercy Kansas City, Kansas City, MO. Kolb EA; Nemours Alfred I. duPont Hospital for Children, Wilmington, DE. Farrar JE; Arkansas Children's Research Institute and Department of Pediatrics, Hematology/Oncology Section, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR. Stirewalt D; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA. Ma X; Computational Biology Department, St. Jude Children's Research Hospital, Memphis, TN. Shaw TI; Computational Biology Department, St. Jude Children's Research Hospital, Memphis, TN. Furlan SN; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA. Brodersen LE; Hematologics, Inc, Seattle, WA. Loken MR; Hematologics, Inc, Seattle, WA. Van den Heuvel-Eibrink MM; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Utrecht University, Utrecht. Zwaan CM; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology/Hematology, Erasmus Medical Center - Sophia Children's Hospital, Rotterdam, the Netherlands; Dutch Childhood Oncology Group. Triche TJ; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA; Department of Translational Genomics, University of Southern California, Los Angeles, CA, USA; Department of Pediatrics, Michigan State University College of Human Medicine, Grand Rapids, MI. Goemans BF; Princess Maxima Center for Pediatric Oncology, Utrecht. Meshinchi S; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA; Children's Oncology Group, Monrovia, CA, USA; Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA. .
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2023 Aug 01; Vol. 108 (8), pp. 2044-2058. Date of Electronic Publication: 2023 Aug 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
Autorzy:
Chisholm KM; Department of Laboratories, Seattle Children's Hospital, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA. Smith J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. Heerema-McKenney AE; Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA. Choi JK; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA. RiesRE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. Hirsch BA; Division of Laboratory Medicine, University of Minnesota Medical Center, Fairview, Minneapolis, Minnesota, USA. Raimondi SC; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Wang YC; Children's Oncology Group, Monrovia, California, USA. Dang A; Children's Oncology Group, Monrovia, California, USA. Alonzo TA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. Sung L; Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada. Aplenc R; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Gamis AS; Children's Mercy Hospitals & Clinics, Kansas City, Missouri, USA. Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. Kahwash SB; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 May; Vol. 70 (5), pp. e30251. Date of Electronic Publication: 2023 Feb 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
Autorzy:
Liu Y; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Klein J; Department of Cell and Molecular Biology and Center for Advanced Genome Editing, St. Jude Children's Research Hospital, Memphis, TN, USA. Bajpai R; Department of Cell and Molecular Biology and Center for Advanced Genome Editing, St. Jude Children's Research Hospital, Memphis, TN, USA. Dong L; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Tran Q; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Kolekar P; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Smith JL; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. RiesRE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Huang BJ; Department of Pediatrics and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Wang YC; Children's Oncology Group, Monrovia, CA, USA. Alonzo TA; Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA. Tian L; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Mulder HL; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Shaw TI; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA. Ma J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. Walsh MP; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. Song G; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. Westover T; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. Autry RJ; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Gout AM; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Wheeler DA; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Wan S; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA. Wu G; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA. Yang JJ; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA. Evans WE; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA. Loh M; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute and the Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA. Easton J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Zhang J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Klco JM; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. . Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. . Brown PA; Bristol Myers Squibb, Princeton, NJ, USA. . Pruett-Miller SM; Department of Cell and Molecular Biology and Center for Advanced Genome Editing, St. Jude Children's Research Hospital, Memphis, TN, USA. . Ma X; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 Apr 05; Vol. 14 (1), pp. 1739. Date of Electronic Publication: 2023 Apr 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Functional consequence and therapeutic targeting of cryptic ALK fusions in monosomy 7 acute myeloid leukemia.
Autorzy:
Manselle MK; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Clinical Research Division, University of Washington, Seattle, Washington, USA. RiesRE; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. Hylkema T; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. Leonti A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. Kirkey DC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Clinical Research Division, University of Washington, Seattle, Washington, USA. Furlan SN; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Clinical Research Division, University of Washington, Seattle, Washington, USA.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Apr; Vol. 70 (4), pp. e30180. Date of Electronic Publication: 2023 Jan 31.
Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes.
Autorzy:
Bolouri H; Center for Systems Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA. . RiesRE; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, USA. Wiedeman AE; Center for Translational Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA. Hylkema T; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, USA. Scheiding S; Center for Translational Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA. Gersuk VH; Center for Systems Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA. O'Brien K; Center for Systems Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA. Nguyen QA; Center for Systems Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA. Smith JL; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, USA.; Research Scientific Computing, Seattle Children's Research Institute, 818 Stewart Street, Seattle, WA, USA. Alice Long S; Center for Translational Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA. Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Nov 23; Vol. 13 (1), pp. 7186. Date of Electronic Publication: 2022 Nov 23.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children's Oncology Group study.
Autorzy:
Hoff FW; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA. Van Dijk AD; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Qiu Y; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Hu CW; Department of Bioengineering, Rice University, Houston, TX, USA. RiesRE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. Ligeralde A; Biophysics, University of California, Berkeley, CA, USA. Jenkins GN; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA. Gerbing RB; University of Southern California, Los Angeles, CA, USA. Gamis AS; Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA. Aplenc R; Division of Pediatric Oncology/Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Kolb EA; Nemours Center for Cancer and Blood Disorders, Emory University, Atlanta GA, USA. Alonzo TA; University of Southern California, Los Angeles, CA, USA. Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. Qutub AA; Department of Biomedical Engineering, The University of Texas at San Antonio, USA;. De Bont ESJM; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Horton TM; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA. Kornblau SM; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. .
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2022 Oct 01; Vol. 107 (10), pp. 2329-2343. Date of Electronic Publication: 2022 Oct 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia.
Autorzy:
Huang BJ; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA. .; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. . Smith JL; Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Farrar JE; University of Arkansas for Medical Sciences & Arkansas Children's Research Institute, Little Rock, AR, USA. Wang YC; Children's Oncology Group, Monrovia, CA, USA. Umeda M; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. RiesRE; Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Leonti AR; Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Crowgey E; Nemours Center for Cancer and Blood Disorders and Alfred I. DuPont Hospital for Children, Wilmington, DE, USA. Furlan SN; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA. Tarlock K; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA. Armendariz M; School of Medicine, University of California, San Francisco, San Francisco, CA, USA. Liu Y; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Shaw TI; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Wei L; Michael Smith Genome Sciences Centre, Vancouver, BC, Canada. Gerbing RB; Children's Oncology Group, Monrovia, CA, USA. Cooper TM; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA. Gamis AS; Children's Mercy Hospitals and Clinics, Kansas City, MO, USA. Aplenc R; Children's Hospital of Philadelphia, Philadelphia, PA, USA. Kolb EA; Nemours Center for Cancer and Blood Disorders and Alfred I. DuPont Hospital for Children, Wilmington, DE, USA. Rubnitz J; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA. Ma J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. Klco JM; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. Ma X; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Alonzo TA; Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA. Triche T Jr; Van Andel Research Institute, Grand Rapids, MI, USA. Meshinchi S; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Sep 19; Vol. 13 (1), pp. 5487. Date of Electronic Publication: 2022 Sep 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Braun TP; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Okhovat M; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA. Coblentz C; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Carratt SA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Foley A; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Schonrock Z; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Curtiss BM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Nevonen K; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA. Davis B; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA. Garcia B; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. LaTocha D; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Weeder BR; Program in Molecular and Cellular Biology, Oregon Health & Science University, Portland, OR, 97239, USA. Grzadkowski MR; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA. Estabrook JC; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA. Manning HG; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA. Watanabe-Smith K; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA. Jeng S; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA. Smith JL; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA. Leonti AR; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA. RiesRE; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA. McWeeney S; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA. Di Genua C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK. Drissen R; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK. Nerlov C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK. Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.; Division of Pediatric Hematology/Oncology, University of Washington, Seattle, WA, 98195, USA. Carbone L; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, 97239, USA. Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.; Howard Hughes Medical Institute, Portland, OR, USA. Maxson JE; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA. .; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Jun 16; Vol. 13 (1), pp. 3471. Date of Electronic Publication: 2022 Jun 16.
The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia.
Autorzy:
Noort S; Pediatric Oncology/Hematology, Erasmus MC-Sophia Children Hospital Rotterdam, The Netherlands. Wander P; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Alonzo TA; Children's Oncology Group, Monrovia, California, USA. Smith J; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. RiesRE; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. Gerbing RB; Children's Oncology Group, Monrovia, California, USA. Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Locatelli F; IRCCS Ospedale Bambino Gesú, Sapienza, University of Rome, Rome, Italy. Reinhardt D; AML-BFM Study Group, Pediatric Hematology and Oncology, Essen, Germany. Baruchel A; University Hospital Robert Debré and Paris Diderot University, Paris, France. Stary J; CPH, University Hospital Motol and Charles University, Prague, Czech Republic. Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Stam RW; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Zwaan MC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Meshinchi S; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, USA.
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2021 Feb 01; Vol. 106 (2), pp. 630-634. Date of Electronic Publication: 2021 Feb 01.
Braun TP; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Okhovat M; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA. Coblentz C; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Carratt SA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Foley A; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Schonrock Z; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Curtiss BM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Nevonen K; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA. Davis B; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA. Garcia B; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. LaTocha D; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. Weeder BR; Program in Molecular and Cellular Biology, Oregon Health & Science University, Portland, OR, 97239, USA. Grzadkowski MR; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA. Estabrook JC; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA. Manning HG; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA. Watanabe-Smith K; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA. Jeng S; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA. Smith JL; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA. Leonti AR; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA. RiesRE; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA. McWeeney S; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA. Di Genua C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK. Drissen R; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK. Nerlov C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK. Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.; Division of Pediatric Hematology/Oncology, University of Washington, Seattle, WA, 98195, USA. Carbone L; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, 97239, USA. Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.; Howard Hughes Medical Institute, Portland, OR, USA. Maxson JE; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA. .; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2019 Nov 29; Vol. 10 (1), pp. 5455. Date of Electronic Publication: 2019 Nov 29.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.
Autorzy:
Ma X; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Liu Y; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Liu Y; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Alexandrov LB; Department of Cellular and Molecular Medicine and Department of Bioengineering and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, USA. Edmonson MN; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Gawad C; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Zhou X; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Li Y; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Rusch MC; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Easton J; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Huether R; Independent Researcher, Chicago, Illinois 60654, USA. Gonzalez-Pena V; Oncology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Wilkinson MR; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Hermida LC; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland 20892, USA. Davis S; Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA. Sioson E; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Pounds S; Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Cao X; Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. RiesRE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. Wang Z; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Chen X; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Dong L; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Diskin SJ; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. Smith MA; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland 20892, USA. Guidry Auvil JM; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland 20892, USA. Meltzer PS; Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA. Lau CC; Division of Hematology-Oncology, Connecticut Children's Medical Center, Hartford, Connecticut 06106, USA.; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, USA. Perlman EJ; Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois 60208, USA. Maris JM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. Hunger SP; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. Gerhard DS; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland 20892, USA. Zhang J; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Pokaż więcej
Źródło:
Nature [Nature] 2018 Mar 15; Vol. 555 (7696), pp. 371-376. Date of Electronic Publication: 2018 Feb 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Autorzy:
Laszlo GS; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. Alonzo TA; Department of Biostatistics, University of Southern California, Los Angeles, CA, USA.; Children's Oncology Group, Monrovia, CA, USA. Gudgeon CJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. Harrington KH; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. Kentsis A; Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, New York, NY, USA.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Medical College of Cornell University, New York, NY, USA. Gerbing RB; Children's Oncology Group, Monrovia, CA, USA. Wang YC; Children's Oncology Group, Monrovia, CA, USA. RiesRE; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. Raimondi SC; Children's Oncology Group, Monrovia, CA, USA.; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. Hirsch BA; Children's Oncology Group, Monrovia, CA, USA.; Department of Laboratory Medicine and Pathology, University of Minnesota Cancer Center, Minneapolis, MN, USA. Gamis AS; Children's Oncology Group, Monrovia, CA, USA.; Division of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA. Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.; Children's Oncology Group, Monrovia, CA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA. Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. .; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA. .; Department of Epidemiology, University of Washington, Seattle, WA, USA. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2016 Nov 30; Vol. 9 (1), pp. 133. Date of Electronic Publication: 2016 Nov 30.
High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Autorzy:
Laszlo GS; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. Alonzo TA; Department of Biostatistics, University of Southern California, Los Angeles, CA, USA.; Children's Oncology Group, Monrovia, CA, USA. Gudgeon CJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. Harrington KH; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. Kentsis A; Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, New York, NY, USA.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Medical College of Cornell University, New York, NY, USA. Gerbing RB; Children's Oncology Group, Monrovia, CA, USA. Wang YC; Children's Oncology Group, Monrovia, CA, USA. RiesRE; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. Raimondi SC; Children's Oncology Group, Monrovia, CA, USA.; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. Hirsch BA; Children's Oncology Group, Monrovia, CA, USA.; Department of Laboratory Medicine and Pathology, University of Minnesota Cancer Center, Minneapolis, MN, USA. Gamis AS; Children's Oncology Group, Monrovia, CA, USA.; Division of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA. Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.; Children's Oncology Group, Monrovia, CA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA. Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. .; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA. .; Department of Epidemiology, University of Washington, Seattle, WA, USA. .
Transcriptome Profiling of Pediatric Core Binding Factor AML.
Autorzy:
Hsu CH; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America. Nguyen C; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America. Yan C; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America. RiesRE; Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America. Chen QR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America. Hu Y; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America. Ostronoff F; Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America. Stirewalt DL; Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America. Komatsoulis G; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America. Levy S; Hudson Alpha Institute for Biotechnology, Huntsville, AL, United States of America. Meerzaman D; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America. Meshinchi S; Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Sep 23; Vol. 10 (9), pp. e0138782. Date of Electronic Publication: 2015 Sep 23 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: a report from the Children's Oncology Group.
Autorzy:
Vujkovic M; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Electronic address: . Attiyeh EF; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. RiesRE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Horn M; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Goodman EK; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Ding Y; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Kavcic M; University Medical Centre, Ljubljana, Slovenia. Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Gerbing RB; Children's Oncology Group, Monrovia, CA, USA. Hirsch B; University of Minnesota, Minneapolis, MN, USA. Raimondi S; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Gamis AS; Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA. Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Aplenc R; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
Cancer genetics [Cancer Genet] 2015 Jul-Aug; Vol. 208 (7-8), pp. 408-13. Date of Electronic Publication: 2015 May 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies